Prof. Dr. SEVTAP ARIKAN AKDAĞLI

Yayın Ağı

Makaleler 96

1. Posaconazole Therapeutic Drug Monitoring in Daily Practice: A Single-Center Analysis

Balaban U., Kara E., Pinar A., Gülmez Kıvanç D., Karakulak E. A., Akdagli S. A., et al.

INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

2. Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM

Cornely O. A., Sprute R., Bassetti M., Chen S. C., Groll A. H., Kurzai O., et al.

LANCET INFECTIOUS DISEASES , sa.5, 2025 (SCI-Expanded, Scopus)

3. Fungal Nomenclature One Fungus, One Name?

Unalan-Altintop T., ARIKAN AKDAĞLI S.

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA , sa.1, ss.57-73, 2025 (SCI-Expanded, Scopus)

4. Impact of Aspergillus PCR on the management of invasive aspergillosis: A tertiary care hospital experience during the COVID-19 pandemic

IŞIK M. C., METAN G., ALP A., GÜLMEZ KIVANÇ D., ARIKAN AKDAĞLI S., UZUN Ö.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE , sa.3, 2025 (SCI-Expanded, Scopus)

5. The impact of the COVID-19 on the antifungal consumption and antifungal resistance in Candida species isolated from the blood cultures of critically ill patients in intensive care units

KARA E., METAN G., Guelmez D., Arikan-Akdagli S.

MEDICAL MYCOLOGY , cilt.63, sa.2, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

6. **New Ester-Containing Azole Derivatives With Potent Anti-Candida Effects: Synthesis, Antifungal Susceptibility, Cytotoxicity, and Molecular Modeling Studies**

Ataker Y., Oncue O., GÜLMEZ KIVANÇ D., SABUNCUOĞLU S., ARIKAN AKDAĞLI S., SARI S.

DRUG DEVELOPMENT RESEARCH , cilt.85, sa.7, 2024 (SCI-Expanded, Scopus)

7. Beyond bacteria: the growing threat of antifungal resistance

van Rhijn N., ARIKAN AKDAĞLI S., Beardsley J., Bongomin F., Chakrabarti A., Chen S. C., et al.

LANCET , cilt.404, sa.10457, ss.1017-1018, 2024 (SCI-Expanded, Scopus)

8. **Insights from Three Pan-European Multicentre Studies on Invasive Candida Infections and Outlook to ECMM Candida IV**

Wolfgruber S., Sedik S., Klingspor L., Tortorano A., Gow N. A. R., Lagrou K., et al.

MYCOPATHOLOGIA , cilt.189, sa.4, 2024 (SCI-Expanded, Scopus)

9. Identification of Malassezia Species in Basal Cell Carcinoma Lesions by Conventional and Molecular Methods

Yildirim S. K., AKDOĞAN KITTANA F. N., ERSOY EVANS S., ALP A., ARIKAN AKDAĞLI S., KARADUMAN A.

DERMATOLOGY PRACTICAL & CONCEPTUAL , cilt.14, sa.3, ss.2-3, 2024 (SCI-Expanded, Scopus)

10. Evaluation of the first Candida auris isolates reported from Türkiye in terms of identification by various methods and susceptibility to antifungal drugs

Genc G. E., Kucukkaya I. C., Komec S., TOKER ÖNDER İ., Toptas O., Teke L., et al.

INDIAN JOURNAL OF MEDICAL MICROBIOLOGY , cilt.49, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

11. Lomentospora prolificans Fungemia in a Patient With T-Cell Large Granular Leukemia: A Rare Pathogen in Türkiye

KAYA E. K., TAŞTEKİN M. B., ARIKAN AKDAĞLI S., GÜLMEZ KIVANÇ D., TOPELİ İSKİT A., UZUN Ö.

MIKROBIYOLOJI BULTENI , cilt.58, sa.2, ss.209-216, 2024 (SCI-Expanded, Scopus, TRDizin)

12. Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM

Bassetti M., Giacobbe D. R., Agvald-Ohman C., AKOVA M., Alastruey-Izquierdo A., ARIKAN AKDAĞLI S., et al.

Intensive Care Medicine , cilt.50, sa.4, ss.502-515, 2024 (SCI-Expanded, Scopus)

13. Invasive fungal rhinosinusitis by Fusarium proliferatum/annulatum in a patient with acute myeloid leukemia: A case report and review of the literature

Caliskan Z. C., Karahan G., Koray N., GÖKÇINAR Y., GÜLMEZ KIVANÇ D., ARIKAN AKDAĞLI S., et al.

Journal of Medical Mycology , cilt.34, sa.1, 2024 (SCI-Expanded, Scopus)

14. Myrtenyl-bispidine containing azole: synthesis and antifungal activity

Li-Zhulanov N. S., Ponomarev K. Y., Sarı S., Gülmez Kıvanç D., Arıkan Akdağlı S., Krasnov V. I., et al.

Mendeleev Communications , cilt.34, sa.1, ss.119-121, 2024 (SCI-Expanded, Scopus)

15. A Case of Relapsing Hyponatremia Associated with Fungal Sinusitis

APAYDIN ROLLAS A. E., ÖNAL C., ÖZBERK U., İNKAYA A. Ç., GÜLMEZ KIVANÇ D., ARIKAN AKDAĞLI S., et al.

CASE REPORTS IN NEPHROLOGY AND DIALYSIS , sa.1, ss.178-184, 2024 (ESCI, Scopus)

16. Predictors for Prolonged Hospital Stay Solely to Complete Intravenous Antifungal Treatment in Patients with Candidemia: Results from the ECMM Candida III Multinational European Observational Cohort Study

Egger M., Salmanton-García J., Barac A., Gangneux J., Guegan H., Arsic-Arsenijevic V., et al.

Mycopathologia , cilt.188, sa.6, ss.983-994, 2023 (SCI-Expanded, Scopus)

17. Diagnostic performance and longitudinal analysis of fungal biomarkers in COVID-19 associated pulmonary aspergillosis

ER B., ER A. G., GÜLMEZ KIVANÇ D., ŞAHİN T. K., METAN G., SARIBAŞ Z., et al.

Heliyon , cilt.9, sa.11, 2023 (SCI-Expanded, Scopus)

18. European candidaemia is characterised by notable differential epidemiology and susceptibility pattern: Results from the ECMM Candida III study

Arendrup M. C., ARIKAN AKDAĞLI S., Jørgensen K. M., Barac A., Steinmann J., Toscano C., et al.

Journal of Infection , cilt.87, sa.5, ss.428-437, 2023 (SCI-Expanded, Scopus)

19. Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study

Hoenigl M., Salmanton-García J., Egger M., Gangneux J., Bicanic T., ARIKAN AKDAĞLI S., et al.

The Lancet Infectious Diseases , cilt.23, sa.6, ss.751-761, 2023 (SCI-Expanded, Scopus)

20. Rational Design of New Monoterpene-Containing Azoles and Their Antifungal Activity

Li-Zhulanov N. S., Zaikova N. P., Sarı S., Gülmez Kıvanç D., Sabuncuoğlu S., Özadalı Sarı K., et al.

Antibiotics , cilt.12, sa.5, 2023 (SCI-Expanded, Scopus)

21. Necrotizing pneumonia due to Aspergillus and Salmonella after immune checkpoint inhibitor treatment: An unusual case and review of the literature Neumonía necrotizante por Aspergillus y Salmonella tras tratamiento con un inhibidor de puntos de control inmunitario: un caso inusual y revisión de la literatura

IŞIK M. C., KARCIOĞLU O., HAZIROLAN G., GÜLMEZ KIVANÇ D., ONUR M. R., KUNT M. M., et al.

Revista Iberoamericana de Micologia , cilt.40, sa.2-3, ss.26-30, 2023 (SCI-Expanded, Scopus)

22. Environmental and bioclimatic factors influencing yeasts and molds distribution along European shores

Cogliati M., ARIKAN AKDAĞLI S., Barac A., Bostanaru A., Brito S., Çerikçioğlu N., et al.

Science of the Total Environment , cilt.859, 2023 (SCI-Expanded, Scopus)

23. The current state of laboratory mycology and access to antifungal treatment in Europe: a European Confederation of Medical Mycology survey

Salmanton-García J., Hoenigl M., Gangneux J., Segal E., Alastruey-Izquierdo A., ARIKAN AKDAĞLI S., et al.

The Lancet Microbe , cilt.4, sa.1, 2023 (Scopus)

24. Multicentre validation of a modified EUCAST MIC testing method and development of associated epidemiologic cut-off (ECOFF) values for rezafungin

Arendrup M. C., ARIKAN AKDAĞLI S., Castanheira M., Guinea J., Locke J. B., Meletiadis J., et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY , cilt.78, ss.185-195, 2022 (SCI-Expanded, Scopus)

25. Impact of Guideline adherence on outcome in Candidemia: Results from the ECMM Candida III multinational European study

Egger M., Honigl M., Salmanton--Garcia J., Arendrup M. C., Kohler P., Gangneux J. P., et al.

MYCOSES , cilt.65, ss.11-12, 2022 (SCI-Expanded, Scopus)

26. Frequency of azole resistance in clinical and environmental strains of Aspergillus fumigatus in Turkey: a multicentre study

ENER B., ERGİN Ç., GÜLMEZ KIVANÇ D., AĞCA H., Tikvesli M., AKSOY S., et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY , cilt.77, ss.1894-1898, 2022 (SCI-Expanded, Scopus)

27. A screening study for COVID-19-associated pulmonary aspergillosis in critically ill patients during the third wave of the pandemic

ER B., ER A. G., GÜLMEZ KIVANÇ D., ŞAHİN T. K., HALAÇLI B., DURHAN G., et al.

MYCOSES , cilt.65, ss.724-732, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

28. A Multidisciplinary Approach to Opportunistic Infections in a Late-presenter Person Living with HIV

Bahar A. R., Bahar Y., UYSAL S., SÖNMEZER M. Ç., GÜLMEZ KIVANÇ D., ÖNDER S. Ç., et al.

Mediterranean Journal of Infection, Microbes and Antimicrobials , cilt.11, sa.1, 2022 (Hakemli Dergi)

29. A Pragmatic Approach to Susceptibility Classification of Yeasts without EUCAST Clinical Breakpoints

Astvad K. M. T., ARIKAN AKDAĞLI S., Arendrup M. C.

JOURNAL OF FUNGI , cilt.8, sa.2, 2022 (SCI-Expanded, Scopus)

30. Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM

Chen S. C., Perfect J., Colombo A. L., Cornely O. A., Groll A. H., Seidel D., et al.

LANCET INFECTIOUS DISEASES , cilt.21, sa.12, 2021 (SCI-Expanded, Scopus)

31. Implementation of Pharmacist-Driven Antifungal Stewardship Program in a Tertiary Care Hospital

KARA E., METAN G., Bayraktar-Ekincioglu A., GÜLMEZ KIVANÇ D., ARIKAN AKDAĞLI S., DEMİRKAZIK F., et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY , cilt.65, sa.9, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

32. The Emergence of Echinocandin-Resistant Candida glabrata Exhibiting High MICs and Related FKS Mutations in Turkey

Sig A. K., SÖNMEZER M. Ç., GÜLMEZ KIVANÇ D., Duyan S., UZUN Ö., ARIKAN AKDAĞLI S.

JOURNAL OF FUNGI , cilt.7, sa.9, 2021 (SCI-Expanded, Scopus)

33. Mycosands: Fungal diversity and abundance in beach sand and recreational waters & mdash; Relevance to human health

Brandao J., Gangneux J. P., Arikan-Akdagli S., Barac A., Bostanaru A. C., Brito S., et al.

SCIENCE OF THE TOTAL ENVIRONMENT , cilt.781, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

34. Species distribution, azole resistance and related molecular mechanisms in invasive Candida parapsilosis complex isolates: Increase in fluconazole resistance in 21 years

Demirci-Duarte S., Arıkan Akdağlı S., Gülmez Kıvanç D.

MYCOSES , cilt.64, sa.8, ss.823-830, 2021 (SCI-Expanded, Scopus)

35. Expect the unexpected: fungemia caused by uncommon Candida species in a Turkish University Hospital

Özyavuz Alp Ş., Gülmez Kıvanç D., Kardaş R. C., Karahan G., Taş Z., Gürsoy G., et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES , cilt.40, sa.7, ss.1539-1545, 2021 (SCI-Expanded, Scopus)

36. Is COVID-19 a risk factor for invasive pulmonary aspergillosis in critically ill patients?

Berrin E. R., Gorkem A. E. R., METAN G., HALAÇLI B., Ersoy E. O., HAZIROLAN G., et al.

TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX , cilt.69, sa.1, ss.118-120, 2021 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

37. MixInYeast: A Multicenter Study on Mixed Yeast Infections

Medina N., Soto-Debran J. C., Seidel D., AKYAR I., Badali H., Barac A., et al.

JOURNAL OF FUNGI , cilt.7, sa.1, 2021 (SCI-Expanded, Scopus)

38. Changing Trends in Isolation Frequencies and Species of Clinical Fungal Strains: What Do the 12-years (2008-2019) Mycology Laboratory Data Tell About?

Gülmez Kıvanç D., Sig A. K., Akar N., Duyan S., Arıkan Akdağlı S.

MIKROBIYOLOJI BULTENI , cilt.55, sa.1, ss.53-66, 2021 (SCI-Expanded, Scopus, TRDizin)

39. A Rare Yeast: Cases of Rhodotorula mucilaginosa Infection Followed Up in a Tertiary University Hospital

Ayaz Ceylan Ç. M., Gülmez Kıvanç D., Arıkan Akdağlı S., Uzun Ö.

MIKROBIYOLOJI BULTENI , cilt.55, sa.1, ss.91-98, 2021 (SCI-Expanded, Scopus, TRDizin)

40. Invasive pulmonary aspergillosis treatment duration in haematology patients in Europe: An EFISG, IDWP-EBMT, EORTC-IDG and SEIFEM survey

Lanternier F., Seidel D., Pagano L., Styczynski J., Mikulska M., Pulcini C., et al.

MYCOSES , cilt.63, sa.5, ss.420-429, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

41. A Rare Presentation of Pulmonary Aspergillosis Bronchial Stump Aspergillosis

Karcioglu O., DOĞAN R., UZUN Ö., TOKAT F., GÜLMEZ KIVANÇ D., ARIKAN AKDAĞLI S., et al.

JOURNAL OF BRONCHOLOGY & INTERVENTIONAL PULMONOLOGY , cilt.27, sa.2, 2020 (ESCI, Scopus)

42. Phenotypic and Genotypic Evaluation of Azole Resistance in Aspergillus fumigatus Isolates from Clinical and Environmental Specimens

DOĞAN Ö., GÜLMEZ KIVANÇ D., ARIKAN AKDAĞLI S.

MIKROBIYOLOJI BULTENI , cilt.54, sa.2, ss.291-305, 2020 (SCI-Expanded, Scopus, TRDizin)

43. Fungal infections of the skin and soft tissue

DOĞAN GÜNAYDIN S., ARIKAN AKDAĞLI S., AKOVA M.

CURRENT OPINION IN INFECTIOUS DISEASES , cilt.33, sa.2, ss.130-136, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

44. A Rare Presentation of Pulmonary Aspergillosis

Karcıoğlu O., DOĞAN R., UZUN Ö., TOKAT F., GÜLMEZ KIVANÇ D., ARIKAN AKDAĞLI S., et al.

JOURNAL OF BRONCHOLOGY & INTERVENTIONAL PULMONOLOGY , cilt.27, sa.2, ss.28-33, 2020 (ESCI, Scopus)

45. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium

Cornely O. A., Alastruey-Izquierdo A., Arenz D., Chen S. C. A., Dannaoui E., Hochhegger B., et al.

LANCET INFECTIOUS DISEASES , cilt.19, sa.12, 2019 (SCI-Expanded, Scopus)

46. ECMM CandiReg-A ready to use platform for outbreaks and epidemiological studies

Koehler P., Arendrup M. C., ARIKAN AKDAĞLI S., Bassetti M., Bretagne S., Klingspor L., et al.

MYCOSES , cilt.62, sa.10, ss.920-927, 2019 (SCI-Expanded, Scopus)

47. Antifungal susceptibility profiles of rare ascomycetous yeasts

Perez-Hansen A., Lass-Floerl C., Lackner M., Aigner M., Alastruey-Izquierdo A., Arikan-Akdagli S., et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY , cilt.74, sa.9, ss.2649-2656, 2019 (SCI-Expanded, Scopus)

48. First multicenter report of in vitro resistance rates in candidemia isolates in Turkey

ARIKAN AKDAĞLI S., GÜLMEZ KIVANÇ D., DOĞAN Ö., ÇERİKÇİOĞLU N., DOLUCA DERELİ M., BİRİNCİ A., et al.

JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE , cilt.18, ss.230-234, 2019 (SCI-Expanded, Scopus)

49. Invasive Mould Infections in Intensive Care Units: Epidemiology, Microbiologic Diagnosis and Antifungal Resistance

Sig A. K., ARIKAN AKDAĞLI S.

JOURNAL OF MEDICAL AND SURGICAL INTENSIVE CARE MEDICINE , cilt.10, sa.2, ss.63-69, 2019 (ESCI, Scopus, TRDizin)

50. Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project

Bassetti M., Scudeller L., Giacobbe D. R., Lamoth F., Righi E., Zuccaro V., et al.

MYCOSES , cilt.62, sa.4, ss.310-319, 2019 (SCI-Expanded, Scopus)

51. Antifungal Resistance: Specific Focus on Multidrug Resistance in Candida auris and Secondary Azole Resistance in Aspergillus fumigatus

ARIKAN AKDAĞLI S., Ghannoum M., Meis J. F.

JOURNAL OF FUNGI , cilt.4, sa.4, 2018 (SCI-Expanded, Scopus)

52. In vitro activities of antifungal drugs against environmental Exophiala isolates and review of the literature

Gulmez D., Dogan O., Boral B., Dogen A., Ilkit M., de Hoog G. S., et al.

MYCOSES , cilt.61, sa.8, ss.561-569, 2018 (SCI-Expanded, Scopus)

53. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

Ullmann A. J., Aguado J. M., Arikan-Akdagli S., Denning D. W., Groll A. H., Lagrou K., et al.

CLINICAL MICROBIOLOGY AND INFECTION , cilt.24, 2018 (SCI-Expanded, Scopus)

54. Pulmonary aspergillosis after treatment with infliximab in Still's disease and a literature review of Still's disease and pulmonary aspergillosis

ŞEYHOĞLU E., ERDEN A., KILIÇ L., KARADAĞ Ö., ARIKAN AKDAĞLI S., AKDOĞAN A., et al.

EUROPEAN JOURNAL OF RHEUMATOLOGY , cilt.5, sa.1, ss.75-78, 2018 (ESCI, TRDizin)

55. Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon?

Zoran T., Sartori B., Sappl L., Aigner M., Sanchez-Reus F., Rezusta A., et al.

FRONTIERS IN MICROBIOLOGY , cilt.9, 2018 (SCI-Expanded, Scopus)

56. A prospective international Aspergillus terreus survey: an EFISG, ISHAM and ECMM joint study

Risslegger B., Zoran T., Lackner M., Aigner M., Sanchez-Reus F., Rezusta A., et al.

CLINICAL MICROBIOLOGY AND INFECTION , cilt.23, sa.10, 2017 (SCI-Expanded, Scopus)

57. Fungemi olgularında hızlı bir ön tanımlama testi Pozitif kan kültürü şişesinden yapılan doğrudan germ tüp testinin değerlendirilmesi

DOĞAN AYÇIK Ö., GÜLMEZ KIVANÇ D., ARIKAN AKDAĞLI S.

ANKEM Dergisi , cilt.30, ss.102-108, 2016 (TRDizin)

58. Evaluation of PNA-FISH Method for Direct Identification of Candida Species in Blood Culture Samples and Its Potential Impact on Guidance of Antifungal Therapy

Dogan O., İNKAYA A. Ç., Gulmez D., UZUN Ö., AKOVA M., ARIKAN AKDAĞLI S.

MIKROBIYOLOJI BULTENI , cilt.50, sa.4, ss.580-589, 2016 (SCI-Expanded, Scopus, TRDizin)

59. Evaluation of Antifungal Efficacy of 0.1% and 0.25% Riboflavin with UVA: A Comparative In Vitro Study

Bilgihan K., KALKANCI A., Ozdemir H. B., Yazar R., Karakurt F., Yuksel E., et al.

CURRENT EYE RESEARCH , cilt.41, sa.8, ss.1050-1056, 2016 (SCI-Expanded, Scopus)

60. Comparison of Microdilution and Disk Diffusion Methods for the Detection of Fluconazole and Voriconazole Susceptibility Against Clinical Candida glabrata Isolates and Determination of Changing Susceptibility with New CLSI Breakpoints

Hazirolan G., SARIBAŞ Z., ARIKAN AKDAĞLI S.

MIKROBIYOLOJI BULTENI , cilt.50, sa.3, ss.428-437, 2016 (SCI-Expanded, Scopus, TRDizin)

61. Is the extraction by Whatman FTA filter matrix technology and sequencing of large ribosomal subunit D1-D2 region sufficient for identification of clinical fungi?

Kiraz N., ÖZ Y., ASLAN H., Erturan Z., ENER B., ARIKAN AKDAĞLI S., et al.

MYCOSES , cilt.58, sa.10, ss.588-597, 2015 (SCI-Expanded, Scopus)

62. Aspergillosis, mucormycosis, and other mould infections: the role of the mycologists

Arikan-Akdagli S.

MYCOSES , cilt.58, ss.28, 2015 (SCI-Expanded, Scopus)

63. In vitro activities of six antifungal drugs against Exophiala spp. isolated from dishwashers and railway sleepers in Turkey

Gulmez D., Dogan-Aycik O., Boral B., Dogen A., İLKİT M. M., de Hoog G. S., et al.

MYCOSES , cilt.58, ss.63, 2015 (SCI-Expanded, Scopus)

64. Epidemiology of candidaemia in a tertiary care university hospital: 10-year experience with 381 candidaemia episodes between 2001 and 2010

Alp S., ARIKAN-AKDAGLI S., GULMEZ D., ASCIOGLU S., UZUN Ö., AKOVA M.

MYCOSES , cilt.58, sa.8, ss.498-505, 2015 (SCI-Expanded, Scopus)

65. Prospective Multicenter International Surveillance of Azole Resistance in Aspergillus fumigatus

van der Linden J. W. M., Arendrup M. C., Warris A., Lagrou K., Pelloux H., Hauser P. M., et al.

EMERGING INFECTIOUS DISEASES , cilt.21, sa.6, ss.1041-1044, 2015 (SCI-Expanded, Scopus)

66. Candidaemia in a paediatric centre and importance of central venous catheter removal

KARADAG-ONCEL E., KARA A., ÖZSÜREKCİ Y., ARIKAN-AKDAGLI S., CENGİZ A. B., CEYHAN M., et al.

MYCOSES , cilt.58, sa.3, ss.140-148, 2015 (SCI-Expanded, Scopus)

67. Aspergillus terreus Infection in a Sutureless Self-sealing Incision Made During Cataract Surgery

ERDEM E., BORAL A. H., ARIKAN AKDAĞLI S., ESEN E., AÇIKALIN A., YAĞMUR M., et al.

MYCOPATHOLOGIA , cilt.179, ss.129-134, 2015 (SCI-Expanded, Scopus)

68. Improvement in the outcome of invasive fusariosis in the last decade

Nucci M., Marr K. A., Vehreschild M. J. G. T., de Souza C. A., Velasco E., Cappellano P., et al.

CLINICAL MICROBIOLOGY AND INFECTION , cilt.20, sa.6, ss.580-585, 2014 (SCI-Expanded, Scopus)

69. ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others

Tortorano A. M., Richardson M., Roilides E., van Diepeningen A., Caira M., Munoz P., et al.

CLINICAL MICROBIOLOGY AND INFECTION , cilt.20, ss.27-46, 2014 (SCI-Expanded, Scopus)

70. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi

Chowdhary A., Meis J. F., Guarro J., de Hoog G. S., Kathuria S., Arendrup M. C., et al.

CLINICAL MICROBIOLOGY AND INFECTION , cilt.20, ss.47-75, 2014 (SCI-Expanded, Scopus)

71. ESCMID dagger and ECMM double dagger joint clinical guidelines for the diagnosis and management of mucormycosis 2013

Cornely O. A., Arikan-Akdagli S., Dannaoui E., Groll A. H., Lagrou K., Chakrabarti A., et al.

CLINICAL MICROBIOLOGY AND INFECTION , cilt.20, ss.5-26, 2014 (SCI-Expanded, Scopus)

72. Epidemiology of antifungal drug resistance

Gomez Lopez A., Arikan-Akdagli S.

MYCOSES , cilt.56, ss.17, 2013 (SCI-Expanded, Scopus)

73. Is the extraction by Whatman FTA filter matrix technology and sequencing of large ribosomal subunit D1/D2 region sufficient for identification of clinical fungi?

Kiraz N., Oz Y., Aslan H., Erturan Z., Ener B., Arikan-Akdagli S., et al.

MYCOSES , cilt.56, ss.136, 2013 (SCI-Expanded, Scopus)

74. Distribution, virulence attributes and antifungal susceptibility patterns of Candida parapsilosis complex strains isolated from clinical samples

TOSUN İ., Akyuz Z., Guler N. C., Gulmez D., BAYRAMOĞLU G., KAKLIKKAYA N., et al.

MEDICAL MYCOLOGY , cilt.51, sa.5, ss.483-492, 2013 (SCI-Expanded, Scopus)

75. Isolation of Scedosporium apiospermum (Teleomorph: Pseudallescheria apiosperma) from an Acute Myeloid Leukemia Patient

ERGİN Ç., KUTLU M., ARIKAN AKDAĞLI S., SARIBAŞ Z., Aydeniz Ozansoy F., SARI İ., et al.

MIKROBIYOLOJI BULTENI , cilt.47, sa.2, ss.351-355, 2013 (SCI-Expanded, Scopus, TRDizin)

76. Head-to-Head Comparison of Inhibitory and Fungicidal Activities of Fluconazole, Itraconazole, Voriconazole, Posaconazole, and Isavuconazole against Clinical Isolates of Trichosporon asahii

HAZIROLAN G., CANTON E., ŞAHİN S., ARIKAN AKDAĞLI S.

Antimicrobial Agents And Chemotherapy , cilt.57, ss.4841-4847, 2013 (SCI-Expanded, Scopus)

77. **ESCMID* guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS**

Lortholary O., Petrikkos G., Akova M., Arendrup M. C., Arikan-Akdagli S., Bassetti M., et al.

CLINICAL MICROBIOLOGY AND INFECTION , cilt.18, ss.68-77, 2012 (SCI-Expanded, Scopus)

78. **ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures**

Cuenca-Estrella M., Verweij P. E., Arendrup M. C., Arikan-Akdagli S., Bille J., Donnelly J. P., et al.

CLINICAL MICROBIOLOGY AND INFECTION , cilt.18, ss.9-18, 2012 (SCI-Expanded, Scopus)

79. **ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.**

Hope W. W., Castagnola E., Groll A. H., Roilides E., Akova M., Arendrup M. C., et al.

CLINICAL MICROBIOLOGY AND INFECTION , cilt.18, ss.38-52, 2012 (SCI-Expanded, Scopus)

80. **ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients**

Cornely O. A., Bassetti M., Calandra T., Garbino J., Kullberg B. J., Lortholary O., et al.

CLINICAL MICROBIOLOGY AND INFECTION , cilt.18, ss.19-37, 2012 (SCI-Expanded, Scopus)

81. **ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)**

Ullmann A. J., Akova M., Herbrecht R., Viscoli C., Arendrup M. C., Arikan-Akdagli S., et al.

CLINICAL MICROBIOLOGY AND INFECTION , cilt.18, ss.53-67, 2012 (SCI-Expanded, Scopus)

82. **ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases**

Ullmann A. J., Cornely O. A., Donnelly J. P., Akova M., Arendrup M. C., Arikan-Akdagli S., et al.

CLINICAL MICROBIOLOGY AND INFECTION , cilt.18, ss.1-8, 2012 (SCI-Expanded, Scopus)

83. Influence of serum on in vitro susceptibility testing of echinocandins for Candida parapsilosis and Candida guilliermondii

SARIBAŞ Z., Yurdakul P., Cetin-Hazirolan G., Arikan-Akdagli S.

MYCOSES , cilt.55, sa.2, ss.156-160, 2012 (SCI-Expanded, Scopus)

84. Azole resistance in Aspergillus: global status in Europe and Asia

Arikan-Akdagli S.

ADVANCES AGAINST ASPERGILLOSIS I , cilt.1272, ss.9-14, 2012 (SCI-Expanded, Scopus)

85. Geotrichum spp.

Arikan-Akdagli S.

MYCOSES , cilt.54, ss.21, 2011 (SCI-Expanded, Scopus)

86. Trichosporon spp.

Arikan-Akdagli S.

MYCOSES , cilt.54, ss.21, 2011 (SCI-Expanded, Scopus)

87. POSTTRAUMATIC PRIMARY CUTANEOUS ASPERGILLOSIS WITH CANDIDA GUILLIERMONDII INFECTION IN A HEALTHY HOST

Turksen Z., Yagci S., Karadag A. S., Tezer A., Taner O. F., Tekin F., et al.

MIKROBIYOLOJI BULTENI , cilt.44, sa.4, ss.665-670, 2010 (SCI-Expanded, Scopus, TRDizin)

88. In Vitro Antifungal Activities of Antimicrobial Coated/Impregnated Central Venous Catheters Against Candida Albicans

Geyik S. G., Gursoy B., SANCAK B., ARIKAN AKDAĞLI S., Yorganci K.

JOURNAL OF MEDICAL AND SURGICAL INTENSIVE CARE MEDICINE , cilt.1, sa.1, ss.10-13, 2010 (ESCI, Scopus)

89. Molecular identification, genotyping, and drug susceptibility of the basidiomycetous yeast pathogen Trichosporon isolated from Turkish patients

Kalkanci A., Sugita T., ARIKAN AKDAĞLI S., Yucesoy M., ENER B., Otag F., et al.

MEDICAL MYCOLOGY , cilt.48, sa.1, ss.141-146, 2010 (SCI-Expanded, Scopus)

90. Fungal Drug Resistance Assays

ARIKAN AKDAĞLI S., Rex J. H.

ANTIMICROBIAL DRUG RESISTANCE, VOL 2: CLINICAL AND EPIDEMIOLOGICAL ASPECTS , ss.1171-1186, 2009 (SCI-Expanded)

91. Systemic phaeohyphomycosis due to Exophiala (Wangiella) in an immunocompetent child

Alabaz D., KİBAR F., ARIKAN AKDAĞLI S., SANCAK B., Celik U., Aksaray N., et al.

MEDICAL MYCOLOGY , cilt.47, sa.6, ss.653-657, 2009 (SCI-Expanded, Scopus)

92. MOLECULAR TYPING OF CLINICAL CANDIDA KRUSEI ISOLATES BY USING RESTRICTION ENDONUCLEASE ANALYSIS OF GENOMIC DNA AND POLYMERASE CHAIN REACTION

SANCAK B., MENEMENLİOĞLU D., Aydin N. G., ERGÜVEN S., ARIKAN AKDAĞLI S.

MIKROBIYOLOJI BULTENI , cilt.42, sa.4, ss.635-644, 2008 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

93. Current status of antifungal susceptibility testing methods

ARIKAN AKDAĞLI S.

MEDICAL MYCOLOGY , cilt.45, sa.7, ss.569-587, 2007 (SCI-Expanded, Scopus)

94. Antifungal Agents

ARIKAN AKDAĞLI S., Rex J. H.

MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED , ss.1949-1960, 2007 (SCI-Expanded)

95. Cryptosporidium parvum prevalence in a group of Turkish children

AKYÖN YILMAZ Y., ERGÜVEN S., ARIKAN AKDAĞLI S., YURDAKÖK K., Günalp A.

Turkish Journal of Pediatrics , cilt.41, ss.189-196, 1999 (SCI-Expanded, Scopus, TRDizin)

96. Cryptosporidiosis in immunocompromised patients in a Turkish University Hospital

ARIKAN AKDAĞLI S., ERGÜVEN S., AKYÖN YILMAZ Y., Günalp A.

Acta Microbiologica Et Immunologica Hungarica , cilt.46, ss.33-40, 1999 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 23

1. Is COVID-19 a risk factor for invasive pulmonary aspergillosis in critically ill patients?

ER B., ER A. G., METAN G., HALAÇLI B., ORTAÇ ERSOY N. E., HAZIROLAN G., et al.

Türk Dahili Cerrahi Yoğun Bakımlar Derneği 17. Ulusal Kongresi, Türkiye, 16 - 18 Kasım 2020, (Özet Bildiri) Sürdürülebilir Kalkınma

2. COVID-19 YOĞUN BAKIM HASTALARINDA INVAZIV PULMONER ASPERGILLOZIS IÇIN BIR RISK FAKTÖRÜ MÜDÜR?

ER B., ER A. G., METAN G., HALAÇLI B., ORTAÇ ERSOY N. E., HAZIROLAN G., et al.

17. Ulusal Dahili ve Cerrahi Bilimler Yoğun Bakım E-Kongresi ve 9. Avrasya Yoğun Bakım E-Toplantısı, 16 Kasım 2020, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

3. Changing trends in genus and species distributions of clinical fungal strains: An evaluation of ten-year data from a tertiary care center in Turkey

GÜLMEZ KIVANÇ D., sığ a. k., akar n., duyan s., ARIKAN AKDAĞLI S.

9th Trends in Medical Mycology, Paris, Fransa, 11 - 14 Ekim 2019, cilt.5, ss.95, (Özet Bildiri)

4. Mixed fungemia within 18-years in a university hospital and antifungal susceptibility profiles of the isolates

GÜLMEZ KIVANÇ D., ÖZYAVUZ ALP Ş., GÜRSOY G., AYAZ Ç. M., DOĞAN Ö., ARIKAN AKDAĞLI S., et al.

Balkan Fungus 2018 First Balkan Conference on Medical Mycology and Mycotoxicology, Temeşvar, Romanya, 13 - 15 Eylül 2018, cilt.26, ss.70-71, (Özet Bildiri)

5. Diverse clinical characteristics of Aspergillus growth in patients with cystic fibrosis. Journal of Cystic Fibrosis

EMİRALİOĞLU N., DOĞRU ERSÖZ D., DOĞAN Ö., GÜLMEZ KIVANÇ D., ARIKAN AKDAĞLI S., Eryılmaz S., et al.

41st European Cystic Fibrosis Conference, Belgrade, Sırbistan Ve Karadağ, 6 - 09 Haziran 2018, cilt.17, ss.78, (Özet Bildiri)

6. Evaluation of Candida spp, risk factors and prognosis among children with candidiasis. P2371.

ARIKAN K. Ö., GÜLMEZ KIVANÇ D., ARIKAN AKDAĞLI S., KARA A., CENGİZ A. B., CEYHAN M.

28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Madrid, İspanya, 21 - 24 Nisan 2018, (Özet Bildiri)

7. Hızla İlerleyen Bir Rinoserebral Mukormikoz Olgusu.

DEMİRCİ S., TOKUÇOĞLU ALTUNAY H., İNKAYA A. Ç., LİSTE Ü., SIĞ A. K., GÜLMEZ KIVANÇ D., et al.

İnfeksiyon Dünyası Çalıştayı, Ankara, Türkiye, 22 - 25 Mart 2018, (Özet Bildiri)

8. Bağışıklık sistemi baskılanmış hastalarda Microsporidia ve fırsatçı bağırsak parazitlerinin varlığının araştırılması

Kaya F., İNKAYA A. Ç., AKSOY S., ABBASOĞLU O., ERTENLİ A. İ., BÜYÜKAŞIK Y., et al.

4. Ulusal Klinik Mikrobiyoloji Kongresi, Türkiye, 8 - 12 Kasım 2017, (Özet Bildiri)

9. Fungemia due to rare yeasts and antifungal susceptibility profiles in a tertiary care university center

ÖZYAVUZ ALP Ş., GÜLMEZ KIVANÇ D., AYAZ Ç. M., ARIKAN AKDAĞLI S., AKOVA M.

8th Trends in Medical Mycology, 6 - 09 Ekim 2017, (Özet Bildiri)

10. The changing epidemiology of candidaemia in a tertiary care university centre. P0959

ÖZYAVUZ ALP Ş., GÜLMEZ KIVANÇ D., ARIKAN AKDAĞLI S., AKOVA M.

27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Viyana, Avusturya, 22 - 25 Nisan 2017, (Özet Bildiri)

11. Fungemi olgularında hızlı bir ön tanımlama testi Pozitif kan kültürü şişesinden yapılan doğrudan germ tüp çimlenme borusu testinin değerlendirilmesi

DOĞAN AYÇIK Ö., GÜLMEZ KIVANÇ D., ARIKAN AKDAĞLI S.

3.Ulusal Klinik Mikrobiyoloji Kongresi, Antalya, Türkiye, 18 - 22 Kasım 2015, (Özet Bildiri)

12. In vitro activities of siz antifungal drugs against Exophiala spp isolated from dishwashers and railway sleepers in Turkey

GÜLMEZ KIVANÇ D., DOĞAN AYÇIK Ö., BORAL B., DÖĞEN A., İLKİT M. M., DE HOOG G. S., et al.

7th Trends in Medical Mycology, Lizbon, Portekiz, 8 - 12 Ekim 2015, cilt.58, ss.51-226, (Özet Bildiri)

13. Kan kültürlerinden izole edilen Candida suşlarında önceki ile karşılaştırmalı olarak yeni CLSı direnç sınır değerlerinin triazol duyarlılık kategorilerinin belirlenmesine etkisi

GÜLMEZ KIVANÇ D., DOĞAN AYÇIK Ö., ARIKAN AKDAĞLI S.

1. Ulusal Tıbbi Mikoloji Kongresi, Ankara, Türkiye, 24 - 26 Eylül 2014, (Özet Bildiri)

14. Kistik Fibrozis Olgularının Solunum Yolu Örneklerinden İzole Edilen Küf Mantarları Hacettepe Üniversitesi Altı Yıllık Mikrobiyolojik Değerlendirme

DOĞAN AYÇIK Ö., GÜLMEZ KIVANÇ D., EMİRALİOĞLU N., YALÇIN e., ARIKAN AKDAĞLI S., ŞENER B.

XXXVI. Türk Mikrobiyoloji Kongresi, Antalya, Türkiye, 12 - 16 Kasım 2014, (Özet Bildiri)

15. Kandidemili olgularda eş zamanlı iki Candida türü saptanma insidansı Hacettepe Üniversitesi Mikoloji Laboratuvarı 1999 2013 verileri

DOĞAN AYÇIK Ö., GÜLMEZ KIVANÇ D., ARIKAN AKDAĞLI S.

8. Ulusal Moleküler ve Tanısal Mikrobiyoloji Kongresi, Ankara, Türkiye, 4 - 07 Haziran 2014, (Özet Bildiri)

16. Kan kültürlerinden izole edilen Candida türlerinin PNA FISH yöntemiyle hızlı tanımlanmasının konvansiyonel tanımlama yöntemleriyle uyum ve antifungal tedavinin yönlendirilmesine olası etki yönünden değerlendirilmesi

DOĞAN AYÇIK Ö., İNKAYA A. Ç., GÜLMEZ KIVANÇ D., UZUN Ö., AKOVA M., ARIKAN AKDAĞLI S.

Febril Nötropeni Klavuz Toplantısı, Ankara, Türkiye, 29 - 30 Mart 2014, (Özet Bildiri)

17. Candida glabrata suşlarında azol grubu antifungal ilaçlara duyarlılık Hacettepe Üniversitesi 2008 2012 verileri 10 Febril Nötropeni Simpozyumu 17 19 Mayıs 2013 Ankara

DOĞAN AYÇIK Ö., GÜLMEZ KIVANÇ D., ARIKAN AKDAĞLI S.

10. Febril Nötropeni Simpozyumu, Ankara, Türkiye, 17 - 19 Mayıs 2013, (Özet Bildiri)

18. Mart 2006 Ocak 2013 yılları arasında Hacettepe Üniversitesi Erişkin Hastanesi nde küf mantarı üremesi olan hastaların dağılımı

HA Y., ARIKAN AKDAĞLI S., GÜLMEZ KIVANÇ D., DOĞAN AYÇIK Ö., AKOVA M.

10. Febril Nötropeni Simpozyumu, Ankara, Türkiye, 17 - 19 Mayıs 2013, (Özet Bildiri) Sürdürülebilir Kalkınma

19. Klinik Örneklerden izole edilen Candida parapsilosis kompleks izolatlarının antifungal duyarlılık profillerinin ve bazı virülans özelliklerinin belirlenmesi

TOSUN İ., AKYÜZ Z., CEBECİ GÜLER N., GÜLMEZ KIVANÇ D., BAYRAMOĞLU G., KAKLIKKAYA N., et al.

35. Türk Mikrobiyoloji Kongresi, Kuşadası, Türkiye, 3 - 07 Kasım 2012, ss.230, (Özet Bildiri)

20. Epidemiology of Candida bloodstream infections and antifungal susceptibility profiles 10 year experience with 381 candidaemia episodes in a tertiary care university centre

ÖZYAVUZ ALP Ş., ARIKAN AKDAĞLI S., GÜLMEZ KIVANÇ D., AŞÇIOĞLU HAYRAN S., UZUN Ö., AKOVA M.

European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Londrina, Birleşik Krallık, 31 Mart - 03 Nisan 2012, (Özet Bildiri)

21. Klinik Örneklerden İzole Edilen Candida glabrata Suşlarının Flukonazol ve Vorikonazole in vitro Duyarlılıklarının Belirlenmesinde Mikrodilüsyon ve Disk Difüzyon Yöntemlerinin Karşılaştırılması

HAZIROLAN G., SARIBAŞ Z., ARIKAN AKDAĞLI S.

I. Ulusal Klinik Mikrobiyoloji Kongresi, Antalya, Türkiye, 12 - 16 Kasım 2011, (Özet Bildiri)

22. Comparıson Of Inhıbıtory And Fungıcıdal Actıvıtıes Of Fıve Trıazoles Agaınst Clınıcal Isolates Of Trichosporon Asahii

HAZIROLAN G., ARIKAN AKDAĞLI S.

4. Trends in Medical Mycology, Atina, Yunanistan, 18 - 21 Ekim 2009, (Özet Bildiri)

23. Influence of serum on in vitro susceptibility testing of echinocandins for Candida parapsilosis and Candida guilliermondii

SARIBAŞ Z., YURDAKUL P., HAZIROLAN G., ARIKAN AKDAĞLI S.

4. Trends in Medical Mycology, Atina, Yunanistan, 18 - 21 Ekim 2009, (Özet Bildiri)

Kitaplar 3

Metrikler

Yayın

128

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

3168

H-İndeks (WoS)

Atıf (Scopus)

361

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Proje

Açık Erişim